Similar articles

• Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.

  Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Bozzette SA, et al. N Engl J Med. 2003 Feb 20;348(8):702-10. doi: 10.1056/NEJMoa022048. N Engl J Med. 2003. PMID: 12594314
• Diabetes mellitus, cardiovascular risk, and HIV disease.

  Grinspoon S. Grinspoon S. Circulation. 2009 Feb 17;119(6):770-2. doi: 10.1161/CIRCULATIONAHA.108.835710. Circulation. 2009. PMID: 19221228 Review. No abstract available.
• Risks of cardiovascular disease in patients receiving antiretroviral therapy for HIV infection: implications for treatment.

  Steinhart CR, Emons MF. Steinhart CR, et al. AIDS Read. 2004 Feb;14(2):86-90, 93-5. AIDS Read. 2004. PMID: 14997864 Review.
• Update on cardiovascular complications in HIV infection.

  Currier JS. Currier JS. Top HIV Med. 2009 Jul-Aug;17(3):98-103. Top HIV Med. 2009. PMID: 19675367 Review.
• Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part II: gender differences.

  Neumann T, Woiwod T, Neumann A, Ross B, Von Birgelen C, Volbracht L, Brockmeyer NH, Gerken G, Erbel R. Neumann T, et al. Eur J Med Res. 2004 Feb 27;9(2):55-60. Eur J Med Res. 2004. PMID: 15090290